Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business
Senti Biosciences
About
  2. Companies
  3. Senti Biosciences
  4. Products
  5. Model SENTI-301 - Multi-Armed ...

Model SENTI-301 - Multi-Armed Allogeneic CAR-NK Cell Therapy for HCC

SHARE

The product profile of SENTI-301 has the potential to promote expansion and persistence of NK cells, and activate and recruit the body’s own immune cells into the solid tumor microenvironment for enhanced anti-tumor activity.

Most popular related searches
natural killer cell
natural killer cell therapy
tumor activity
carcinoma hcc
immune cell
tumor microenvironment
hepatocellular carcinoma
solid tumor
cell therapy
allogeneic cell

Pursuing an Unmet Need in the Treatment of HCC

SENTI-301 is designed to target glypican 3, or GPC3, which is highly expressed in 70% to 90% of hepatocellular carcinoma (HCC) cases. Our vision is a potential medicine that enhances anti-tumor activity.